Search - tctmd.com

Displaying 1 - 20 of 38

Sort: Relevancy | Date

News Daily News

The Biggest News of 2018: TCTMD’s Top 10

Shelley Wood

December 31, 2018

News Daily News

Need to Spin a Negative Trial? Consult the Playbook

Todd Neale

December 20, 2018

News Daily News

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

L.A. McKeown

December 18, 2018

News Conference News WCC 2018

True Resistant Hypertension Is Prevalent Worldwide

Todd Neale

December 07, 2018

News Daily News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Michael O'Riordan

December 06, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2018

Shelley Wood

November 30, 2018

News Conference News AHA 2018

PIONEER-HF: Sacubitril/Valsartan Safe and Effective in Acute Decompensated Heart Failure

Michael O'Riordan

November 11, 2018

News Daily News

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

Michael O'Riordan

November 06, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2018

Shelley Wood

October 31, 2018

News Features

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

Shelley Wood

October 22, 2018

News Opinion Off Script TCT 2018

Off Script: Phantom Hearts and the Elusive Nature of Angina

Kwan S. Lee

October 11, 2018

News Conference News TCT 2018

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

Michael O'Riordan

October 02, 2018

Presentation TCT 2018

Device Therapy Offers a Viable Alternative to Medical Therapy, and Should Be Considered as a Reasonable Alternative!

Presenter: Joost Daemen

September 24, 2018

Polymer-Free BioFreedom Stent as Safe as Orsiro, but Not as Effective

News Conference News TCT 2018

CORRECTION: Polymer-Free BioFreedom Stent Faces Off Against Orsiro

Michael O'Riordan

September 22, 2018

News Conference News TCT 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Shelley Wood

September 17, 2018

News Conference News ESC 2018

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

Shelley Wood

September 14, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2018

Caitlin E. Cox

September 04, 2018

News Conference News ESC 2018

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Shelley Wood

August 20, 2018

News Conference News The Structural Heart Disease Summit 2018

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Michael O'Riordan

June 22, 2018

News Daily News

New European Hypertension Guidelines Not in Harmony With US Guidance

Todd Neale

June 11, 2018

Advertisement

The Biggest News of 2018: TCTMD’s Top 10

Need to Spin a Negative Trial? Consult the Playbook

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

True Resistant Hypertension Is Prevalent Worldwide

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

TCTMD’s Top 10 Most Popular Stories for November 2018

PIONEER-HF: Sacubitril/Valsartan Safe and Effective in Acute Decompensated Heart Failure

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

TCTMD’s Top 10 Most Popular Stories for October 2018

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

Off Script: Phantom Hearts and the Elusive Nature of Angina

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

Device Therapy Offers a Viable Alternative to Medical Therapy, and Should Be Considered as a Reasonable Alternative!

CORRECTION: Polymer-Free BioFreedom Stent Faces Off Against Orsiro

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

TCTMD’s Top 10 Most Popular Stories for August 2018

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

New European Hypertension Guidelines Not in Harmony With US Guidance

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content